After Launching First Pegylated GCSF, Intas Biopharma Examines Technology For Pegylated Erythropoietin
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Ahmedabad, India-based biotech firm Intas Biopharma is looking at commencing research on a generic form of pegylated erythropoietin